Skip to main content
NCBI home page
Journal of Accident & Emergency Medicine logoLink to Journal of Accident & Emergency Medicine
. 1999 Jan;16(1):2–7. doi: 10.1136/emj.16.1.2

Stroke--a medical emergency.

C Lott 1, H J Hennes 1, W Dick 1
PMCID: PMC1343243  PMID: 9918277

Abstract

Stroke is the third leading cause of death and number one cause of disability in industrialised countries. A number of new therapeutic approaches are currently in development for use in the acute phase of ischaemic stroke and all trials have, to date, demonstrated the importance of early diagnosis and subsequent initiation of treatment. It is well known that, for most patients, there is a long delay between the onset of symptoms and the start of treatment. A number of factors are responsible for this time delay: signs and symptoms often go unrecognised by patients, relatives, and bystanders and, unlike trauma or myocardial infarction, stroke is not given a high priority by medical staff. Studies into the pathophysiology of acute ischaemic stroke have indicated that treatment options are likely to be optimised when early signs of stroke are recognised and treatment is initiated within six hours of symptom onset. Although a small number of stroke patients are treated as emergencies and attended to by the emergency medical services within this time window, this number could easily be increased by intensified public and emergency personnel education. In the future, it is hoped that treatments which must be administered within the first few hours of acute stroke will be able to be initiated by the emergency medical services. In the same way that hospitals are notified and prepared in advance to receive trauma victims, early notification by the emergency medical services about stroke patients would enable stroke teams to be present at admission, thus improving the likelihood of a better outcome for patients.

Full text

PDF
2

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. A randomized trial of tirilazad mesylate in patients with acute stroke (RANTTAS). The RANTTAS Investigators. Stroke. 1996 Sep;27(9):1453–1458. doi: 10.1161/01.str.27.9.1453. [DOI] [PubMed] [Google Scholar]
  2. Adams H. P., Jr, Brott T. G., Furlan A. J., Gomez C. R., Grotta J., Helgason C. M., Kwiatkowski T., Lyden P. D., Marler J. R., Torner J. Guidelines for Thrombolytic Therapy for Acute Stroke: a Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Stroke. 1996 Sep;27(9):1711–1718. [PubMed] [Google Scholar]
  3. Adams H. P., Jr, Brott T. G., Furlan A. J., Gomez C. R., Grotta J., Helgason C. M., Kwiatkowski T., Lyden P. D., Marler J. R., Torner J. Guidelines for Thrombolytic Therapy for Acute Stroke: a Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Stroke. 1996 Sep;27(9):1711–1718. [PubMed] [Google Scholar]
  4. Alberts M. J., Perry A., Dawson D. V., Bertels C. Effects of public and professional education on reducing the delay in presentation and referral of stroke patients. Stroke. 1992 Mar;23(3):352–356. doi: 10.1161/01.str.23.3.352. [DOI] [PubMed] [Google Scholar]
  5. Allen C. M. Clinical diagnosis of the acute stroke syndrome. Q J Med. 1983 Autumn;52(208):515–523. [PubMed] [Google Scholar]
  6. Astrup J., Siesjö B. K., Symon L. Thresholds in cerebral ischemia - the ischemic penumbra. Stroke. 1981 Nov-Dec;12(6):723–725. doi: 10.1161/01.str.12.6.723. [DOI] [PubMed] [Google Scholar]
  7. Bronstein K. S., Chadwick L. R. Ticlopidine hydrochloride: its current use in cerebrovascular disease. Rehabil Nurs. 1994 Jan-Feb;19(1):17–20. doi: 10.1002/j.2048-7940.1994.tb01297.x. [DOI] [PubMed] [Google Scholar]
  8. Curzen N. P., Jourdan K. B., Mitchell J. A. Endothelial modification of pulmonary vascular tone. Intensive Care Med. 1996 Jun;22(6):596–607. doi: 10.1007/BF01708105. [DOI] [PubMed] [Google Scholar]
  9. Diener H. C., Hacke W., Hennerici M., Rådberg J., Hantson L., De Keyser J. Lubeluzole in acute ischemic stroke. A double-blind, placebo-controlled phase II trial. Lubeluzole International Study Group. Stroke. 1996 Jan;27(1):76–81. doi: 10.1161/01.str.27.1.76. [DOI] [PubMed] [Google Scholar]
  10. Donnan G. A., Davis S. M., Chambers B. R., Gates P. C., Hankey G. J., McNeil J. J., Rosen D., Stewart-Wynne E. G., Tuck R. R. Trials of streptokinase in severe acute ischaemic stroke. Lancet. 1995 Mar 4;345(8949):578–579. [PubMed] [Google Scholar]
  11. Hacke W., Kaste M., Fieschi C., Toni D., Lesaffre E., von Kummer R., Boysen G., Bluhmki E., Höxter G., Mahagne M. H. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) JAMA. 1995 Oct 4;274(13):1017–1025. [PubMed] [Google Scholar]
  12. Hacke W., Stingele R., Steiner T., Schuchardt V., Schwab S. Critical care of acute ischemic stroke. Intensive Care Med. 1995 Oct;21(10):856–862. doi: 10.1007/BF01700973. [DOI] [PubMed] [Google Scholar]
  13. Kothari R., Barsan W., Brott T., Broderick J., Ashbrock S. Frequency and accuracy of prehospital diagnosis of acute stroke. Stroke. 1995 Jun;26(6):937–941. doi: 10.1161/01.str.26.6.937. [DOI] [PubMed] [Google Scholar]
  14. McDonald J. W., Silverstein F. S., Johnston M. V. Magnesium reduces N-methyl-D-aspartate (NMDA)-mediated brain injury in perinatal rats. Neurosci Lett. 1990 Feb 5;109(1-2):234–238. doi: 10.1016/0304-3940(90)90569-u. [DOI] [PubMed] [Google Scholar]
  15. Muir K. W., Lees K. R. Clinical experience with excitatory amino acid antagonist drugs. Stroke. 1995 Mar;26(3):503–513. doi: 10.1161/01.str.26.3.503. [DOI] [PubMed] [Google Scholar]
  16. Poungvarin N., Viriyavejakul A., Komontri C. Siriraj stroke score and validation study to distinguish supratentorial intracerebral haemorrhage from infarction. BMJ. 1991 Jun 29;302(6792):1565–1567. doi: 10.1136/bmj.302.6792.1565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Solis O. J., Roberson G. R., Taveras J. M., Mohr J., Pessin M. Cerebral angiography in acute cerebral infarction. Rev Interam Radiol. 1977 Jan;2(1):19–25. [PubMed] [Google Scholar]
  18. Spitzer K., Becker V., Thie A., Kunze K. The Hamburg Stroke Data Bank: goals, design and preliminary results. J Neurol. 1989 Mar;236(3):139–144. doi: 10.1007/BF00314328. [DOI] [PubMed] [Google Scholar]
  19. Thorvaldsen P., Asplund K., Kuulasmaa K., Rajakangas A. M., Schroll M. Stroke incidence, case fatality, and mortality in the WHO MONICA project. World Health Organization Monitoring Trends and Determinants in Cardiovascular Disease. Stroke. 1995 Mar;26(3):361–367. doi: 10.1161/01.str.26.3.361. [DOI] [PubMed] [Google Scholar]
  20. Young W., Wojak J. C., DeCrescito V. 21-Aminosteroid reduces ion shifts and edema in the rat middle cerebral artery occlusion model of regional ischemia. Stroke. 1988 Aug;19(8):1013–1019. doi: 10.1161/01.str.19.8.1013. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Accident & Emergency Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES